Teleflex shares rise on Q2 beat and raise

Share

TeleflexShares in Teleflex (NYSE:TFX) rose today after the medical device maker topped expectations on Wall Street with its 2nd quarter earnings results, providing lifted guidance for the rest of its fiscal year.

The Wayne, Pa.-based company posted profits of $78 million, or $1.67 per share, on sales of $528.6 million for the 3 months ended June 30, for bottom-line growth of 30.9% while sales grew 11.4% compared with the same period last year.

Read the whole story on our sister site, MassDevice.com

Join us in Southern California this December for DeviceTalks West on 12/11-12/12

textadimage We've attracted a diverse group of thought leaders from some of the Golden State's best medtech companies — including Bigfoot Biomedical, BD, Alphabet's Verily, Integer, Medtronic Neurovascular, Medtronic Diabetes, Smith & Nephew and many more for DeviceTalks West.

Check out our web site for latest news on speakers, agenda and event information.


Get your tickets today! »

Speak Your Mind

*